Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo D'Amore

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Recenti Progressi in Medicina|August 18, 2006
[Complication after vertebroplasty in patient with senile osteoporosis: strategical therapy to revise?]Giovanna Minenna, Simona D'Amore, Massimo D'Amore
Recenti Progressi in Medicina|May 30, 2006
[Biohumoral and densitometry evaluation in a group of postmenopausal women]Massimo D'Amore, Simona D'Amore, Giovanna Minenna
Recenti Progressi in Medicina|February 28, 2006
[Adverse events in rheumatoid arthritis patient with etanercept therapy: the appearance of osteomalacia]Massimo D'Amore, Giovanna Minenna, Simona D'Amore
Immunology Letters|August 31, 2014
ADAM17 at the interface between inflammation and autoimmunitySabrina Lisi, Massimo D'Amore, Margherita Sisto
Recenti Progressi in Medicina|June 4, 2005
[New therapeutic perspectives in Sjögren syndrome: leflunomide]Pasquale Scagliusi, Giovanna Minenna, Massimo D'Amore, et al.
Recenti Progressi in Medicina|March 10, 2007
[Dermatomyositis and hypokalemia: a difficult diagnosis]Giovanna Minenna, Livia Albanese, Simona D'Amore, et al.
Clinical and Experimental Medicine|March 26, 2014
The metalloproteinase ADAM17 and the epidermal growth factor receptor (EGFR) signaling drive the inflammatory epithelial response in Sjögren's syndromeMargherita Sisto, Sabrina Lisi, Massimo D'Amore, et al.
Immunology|March 25, 2014
Rituximab-mediated Raf kinase inhibitor protein induction modulates NF-κB in Sjögren syndromeMargherita Sisto, Sabrina Lisi, Massimo D'Amore, et al.
International Immunology|November 10, 2014
Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathwaySabrina Lisi, Margherita Sisto, Massimo D'Amore, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 14, 2011
Sjögren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κBSabrina Lisi, Margherita Sisto, Dario Domenico Lofrumento, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Recenti Progressi in Medicina|August 18, 2006
[Complication after vertebroplasty in patient with senile osteoporosis: strategical therapy to revise?]Giovanna Minenna, Simona D'Amore, Massimo D'Amore
Recenti Progressi in Medicina|May 30, 2006
[Biohumoral and densitometry evaluation in a group of postmenopausal women]Massimo D'Amore, Simona D'Amore, Giovanna Minenna
Recenti Progressi in Medicina|February 28, 2006
[Adverse events in rheumatoid arthritis patient with etanercept therapy: the appearance of osteomalacia]Massimo D'Amore, Giovanna Minenna, Simona D'Amore
Immunology Letters|August 31, 2014
ADAM17 at the interface between inflammation and autoimmunitySabrina Lisi, Massimo D'Amore, Margherita Sisto
Recenti Progressi in Medicina|June 4, 2005
[New therapeutic perspectives in Sjögren syndrome: leflunomide]Pasquale Scagliusi, Giovanna Minenna, Massimo D'Amore, et al.
Recenti Progressi in Medicina|March 10, 2007
[Dermatomyositis and hypokalemia: a difficult diagnosis]Giovanna Minenna, Livia Albanese, Simona D'Amore, et al.
Clinical and Experimental Medicine|March 26, 2014
The metalloproteinase ADAM17 and the epidermal growth factor receptor (EGFR) signaling drive the inflammatory epithelial response in Sjögren's syndromeMargherita Sisto, Sabrina Lisi, Massimo D'Amore, et al.
Immunology|March 25, 2014
Rituximab-mediated Raf kinase inhibitor protein induction modulates NF-κB in Sjögren syndromeMargherita Sisto, Sabrina Lisi, Massimo D'Amore, et al.
International Immunology|November 10, 2014
Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathwaySabrina Lisi, Margherita Sisto, Massimo D'Amore, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 14, 2011
Sjögren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κBSabrina Lisi, Margherita Sisto, Dario Domenico Lofrumento, et al.
Pageof 5